Skip to main content
Signal8
Bain Linda profile photo

Linda Bain

CIK: 0001578407

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Autolus Therapeutics plc logo
AUTL

Autolus Therapeutics plc

Director
ARVINAS, INC. logo
ARVN

ARVINAS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Autolus Therapeutics plc logo
    AUTL

    Autolus Therapeutics plc

    Jun 29, 2026
    Award(A)

    Restricted Share Units

    Direct
    31.7K shares-
  • Autolus Therapeutics plc logo
    AUTL

    Autolus Therapeutics plc

    Jun 29, 2026
    Award(A)

    Share Option (Right to Buy)

    Direct
    47.5K shares-
  • ARVINAS, INC. logo
    ARVN

    ARVINAS, INC.

    Jun 24, 2026
    Award(A)
    Direct
    15.5K shares-
  • ARVINAS, INC. logo
    ARVN

    ARVINAS, INC.

    Jun 25, 2025
    Award(A)
    Direct
    16K shares-

1-4 of 4

About Bain Linda

Bain Linda (SEC CIK 0001578407) files insider reports with the SEC as Director of Autolus Therapeutics plc (AUTL) and Director of ARVINAS, INC. (ARVN).

Signal8 holds 4 ownership filings by Bain Linda (1 Form 3, 3 Form 4), filed between Jun 27, 2025 and Jul 1, 2026. Those filings report 4 transactions, from Jun 25, 2025 to Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bain Linda's filings is in LONDON.

Recent filings by Bain Linda

  • Jun 29, 2026: Grants or awards of AUTL derivative securities (2 lines, Form 4, code A).
  • Jun 24, 2026: Grant or award of ARVN shares (Form 4, code A).
  • Jun 25, 2025: Grant or award of ARVN shares (Form 4, code A).

Other insiders filing for Autolus Therapeutics plc (AUTL)

How to read Form 4 transaction codes